Medicenna Therapeutics Corp
TSX:MDNA
Income Statement
Earnings Waterfall
Medicenna Therapeutics Corp
Income Statement
Medicenna Therapeutics Corp
| Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(4)
|
(6)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(10)
|
(11)
|
(14)
|
(17)
|
(21)
|
(25)
|
(25)
|
(22)
|
(21)
|
(17)
|
(17)
|
(16)
|
(16)
|
(17)
|
(17)
|
(19)
|
(18)
|
(18)
|
(19)
|
(20)
|
(22)
|
(22)
|
(22)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(6)
|
(8)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(5)
|
(5)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
(4)
|
(5)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(11)
|
(15)
|
(19)
|
(19)
|
(16)
|
(13)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(14)
|
(16)
|
(16)
|
(17)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-10%
|
(0)
N/A
|
(0)
+64%
|
(0)
-13%
|
(2)
-2 478%
|
(4)
-72%
|
(6)
-53%
|
(7)
-21%
|
(6)
+16%
|
(5)
+13%
|
(5)
+9%
|
(5)
+4%
|
(5)
-5%
|
(6)
-20%
|
(7)
-11%
|
(8)
-24%
|
(10)
-15%
|
(11)
-21%
|
(14)
-25%
|
(17)
-21%
|
(21)
-21%
|
(25)
-21%
|
(25)
+1%
|
(22)
+10%
|
(21)
+8%
|
(17)
+17%
|
(17)
0%
|
(16)
+5%
|
(16)
-1%
|
(17)
-4%
|
(17)
+1%
|
(19)
-10%
|
(18)
+2%
|
(18)
0%
|
(19)
-2%
|
(20)
-9%
|
(22)
-7%
|
(22)
+0%
|
(22)
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
4
|
8
|
6
|
8
|
6
|
2
|
(7)
|
(8)
|
(8)
|
(8)
|
9
|
9
|
8
|
9
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-10%
|
(0)
N/A
|
(0)
+64%
|
(0)
-13%
|
(2)
-2 489%
|
(4)
-73%
|
(6)
-53%
|
(7)
-21%
|
(6)
+16%
|
(5)
+13%
|
(5)
+8%
|
(5)
+5%
|
(5)
-5%
|
(6)
-20%
|
(7)
-11%
|
(8)
-25%
|
(9)
-13%
|
(11)
-20%
|
(14)
-26%
|
(17)
-22%
|
(21)
-23%
|
(26)
-21%
|
(25)
+2%
|
(23)
+10%
|
(20)
+10%
|
(13)
+36%
|
(9)
+28%
|
(10)
-7%
|
(9)
+13%
|
(12)
-32%
|
(15)
-33%
|
(25)
-65%
|
(26)
-3%
|
(27)
-2%
|
(27)
-1%
|
(12)
+56%
|
(13)
-11%
|
(14)
-5%
|
(13)
+6%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(4)
|
(6)
|
(7)
|
(6)
|
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(11)
|
(14)
|
(17)
|
(21)
|
(26)
|
(25)
|
(23)
|
(20)
|
(13)
|
(9)
|
(10)
|
(9)
|
(12)
|
(15)
|
(25)
|
(26)
|
(27)
|
(27)
|
(12)
|
(13)
|
(14)
|
(13)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-10%
|
(0)
N/A
|
(0)
+64%
|
(0)
-13%
|
(2)
-2 489%
|
(4)
-73%
|
(6)
-53%
|
(7)
-21%
|
(6)
+16%
|
(5)
+13%
|
(5)
+8%
|
(5)
+5%
|
(5)
-5%
|
(6)
-20%
|
(7)
-11%
|
(8)
-25%
|
(9)
-13%
|
(11)
-20%
|
(14)
-26%
|
(17)
-22%
|
(21)
-23%
|
(26)
-21%
|
(25)
+2%
|
(23)
+10%
|
(20)
+10%
|
(13)
+36%
|
(9)
+28%
|
(10)
-7%
|
(9)
+13%
|
(12)
-32%
|
(15)
-33%
|
(25)
-65%
|
(26)
-3%
|
(27)
-2%
|
(27)
-1%
|
(12)
+56%
|
(13)
-11%
|
(14)
-5%
|
(13)
+6%
|
|
| EPS (Diluted) |
-0.19
N/A
|
-0.2
-5%
|
-0.2
N/A
|
-0.07
+65%
|
-0.08
-14%
|
-0.09
-12%
|
-0.16
-78%
|
-0.25
-56%
|
-0.3
-20%
|
-0.25
+17%
|
-0.22
+12%
|
-0.2
+9%
|
-0.18
+10%
|
-0.17
+6%
|
-0.2
-18%
|
-0.19
+5%
|
-0.26
-37%
|
-0.19
+27%
|
-0.22
-16%
|
-0.28
-27%
|
-0.35
-25%
|
-0.39
-11%
|
-0.49
-26%
|
-0.47
+4%
|
-0.42
+11%
|
-0.37
+12%
|
-0.2
+46%
|
-0.13
+35%
|
-0.16
-23%
|
-0.13
+19%
|
-0.17
-31%
|
-0.22
-29%
|
-0.37
-68%
|
-0.37
N/A
|
-0.34
+8%
|
-0.34
N/A
|
-0.15
+56%
|
-0.17
-13%
|
-0.17
N/A
|
-0.16
+6%
|
|